SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The company's total revenue for the quarter ended September 2022 saw a slight change in the total revenue, having registered a total revenue of Rs. 5414.10 millions.A big decline of -49.19% was reported for the quarter ended September 2022 to Rs. 156.70  millions from Rs. 308.40 millions of corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 367.30 millions from 543.10 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 5414.10 5378.80 0.66 11064.20 10563.90 4.74 21840.20 19669.80 11.03
Other Income 50.60 105.10 -51.86 102.10 162.30 -37.09 320.40 243.00 31.85
PBIDT 367.30 543.10 -32.37 979.00 1701.80 -42.47 2883.20 6161.40 -53.21
Interest 35.10 18.90 85.71 68.90 36.60 88.25 82.90 58.30 42.20
PBDT 332.20 524.20 -36.63 910.10 1525.90 -40.36 2661.00 6103.10 -56.40
Depreciation 113.20 108.00 4.81 223.00 211.20 5.59 432.60 389.20 11.15
PBT 219.00 416.20 -47.38 687.10 1314.70 -47.74 2228.40 5713.90 -61.00
TAX 62.30 107.80 -42.21 181.50 336.30 -46.03 571.80 1268.30 -54.92
Deferred Tax 5.40 3.30 63.64 3.00 -2.90 -203.45 1.70 -187.20 -100.91
PAT 156.70 308.40 -49.19 505.60 978.40 -48.32 1656.60 4445.60 -62.74
Equity 587.10 587.10 0.00 587.10 587.10 0.00 587.10 587.10 0.00
PBIDTM(%) 6.78 10.10 -32.81 8.85 16.11 -45.07 13.20 31.32 -57.86

IOL Chem & Pharma Share Price

96.98 -0.90 (-0.92%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×